SCHEMBL5670929

SCHEMBL5670929

Nc1nnc(-c2nonc2NC(=O)O)o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
NOTUM Q6P988 2/20 0.35
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
POLB P06746 1/20 0.33
THRB P10828 1/20 0.32
STAT3 P40763 1/20 0.31
STAT1 P42224 1/20 0.31
TP53 P04637 2/20 0.31
LMNA P02545 1/20 0.31
RXFP1 Q9HBX9 1/20 0.30
DGAT1 O75907 1/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10809929 0.64 SMN1; SMN2 (0.51) TSHRMEN1KMT2APOLBTP53
SCHEMBL5733596 0.57 NPC1 (0.69) NOTUMKDM4EMEN1KMT2ADGAT1
SCHEMBL29156966 0.54 PTPN1 (0.41) NOTUM
SCHEMBL3979 0.53 NOTUM (1.00) NOTUMKDM4EMEN1KMT2APOLB
SCHEMBL10504942 0.52 TSHR (0.51) TSHRKDM4EKMT2APOLBRXFP1
SCHEMBL19597568 0.52 ATR (0.44) KDM4EMAPTALDH1A1HTT
SCHEMBL21827122 0.52 TLR8 (0.40) KDM4ECYP1A2
SCHEMBL19899559 0.51
Carbamic Acid SCHEMBL3227372 0.50 KDM4E (0.57) TSHRKDM4EMEN1KMT2ALMNA
SCHEMBL13870132 0.49 SMN1; SMN2 (0.59) MEN1KMT2APOLBTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660467-A2 AMINOFURAZAN COMPOUNDS AS PROTEIN KINASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2006-05-31 EP disclosed
WO-2005019190-A2 (4 -AMINO -1,2, 5-OXADIAZOL-4-YL) -HETΞROAROMATIC COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-03-03 WO disclosed